Recent Center Publications
Center authors noted by bold text.
Abarca J, Malone DC, Skrepnek GH, Rehfeld RA, Murphy JE, Grizzle AJ, Armstrong EP, Woosley RL. Community pharmacy managers’ perception of computerized drug-drug interaction alerts. Journal of the American Pharmacist Association 2006; 46(2):148-153.
Abarca J, Colon LR, Wang VS, Malone DC, Murphy JE, Armstrong EP. Evaluation of drug-drug interaction screening software in community and hospital pharmacies. Journal of Managed Care Pharmacy 2006; 12:383-389.
Abarca J; Malone DC; Armstrong EP; Grizzle AJ; Cohen MD. Longitudinal analysis of the use of etanercept versus infliximab determined from a medical chart audit. Journal of Managed Care Pharmacy 2004; 10:538-542.
Abarca J, Malone DC, Armstrong EP, Zachry III WM. Use of ace inhibitor therapy among patients with congestive heart failure enrolled in a managed care organization: the effect on hospitalization and costs. Pharmacotherapy 2004; 24: 351-357.
Abarca J, Malone DC, Armstrong EP, Grizzle AJ, Hansten PD, Van Bergen R, Lipton RB. Concordance of major drug interaction classifications among drug interaction compendia. Journal of the American Pharmacist Association 2004; 44:136-141.
Abarca J, Armstrong EP. Improving the use of data sources in disease management program. Disease Management and Health Outcomes 2001.
Abarca J, Armstrong EP. Multiple logistic regression: a statistical method to evaluate predictors of hospitalizations. Formulary 2000; 35:832-41.
Akaho E, Armstrong EP, Fujii M. Pharmaceutical care innovations in Japan. Journal of the American Pharmaceutical Association 1996; NS36:123-7.
Alsuwaidan S, Malone DC, Billups SJ, Carter BL. Description of ambulatory care services provided by veterans affairs medical centers. American Journal of Health-Systems Pharmacy 1998; 55:68-73.
Armstrong EP, Skrepnek GH, Erder MH. Cost-Utility Comparison of Escitalopram and Sertraline in the Treatment of Major Depressive Disorder. Current Medical Research and Opinion 2007; 23:251-258.
Armstrong EP, Zachry WM III, Malone DC. Cost-effectiveness analysis of simvastatin and lovastatin/extended-release niacin to achieve LDL and HDL goal using NHANES data. Journal of Managed Care Pharmacy 2004; 10:251-258.
Armstrong EP, Bates SM, Jones WN. Nonsteroidal anti-inflammatory drugs, minimizing gastrointestinal toxicity. Federal Practitioner 2003; 20:11-23.
Armstrong EP. Antidepressant Treatment Patterns and Success Rates in a Managed Care Organization. Disease Management and Health Outcomes 2003; 11:173-80.
Armstrong EP, Malone DC. The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents. Clinical Therapeutics 2003; 25:1-18.
Armstrong EP, Malone DC. Fluticasone propionate is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis. Pharmacotherapy 2002; 22:1117-23.
Armstrong EP, Abarca J. An examination of the relationship between non-depression- related costs and uninterrupted Tx. Formulary 2001; 36:461-8.
Armstrong EP. Analysis of antidepressant use through hierarchical disease analysis. Disease Management and Health Outcomes 2001; 9:255-67.
Armstrong EP, Krueger K, Langley PC. Analysis of asthma costs and patterns of resource utilization in a managed care population. Disease Management and Health Outcomes 2001; 9:161-71.
Armstrong EP, Abarca J, Grizzle AJ. The role of pharmacoeconomic information from the pharmaceutical industry perspective. Drug Benefit Trends 2001; 13:39-45.
Armstrong EP. Clinical and economic outcomes of an ambulatory urinary tract infection disease management program. American Journal of Managed Care 2001; 7:269-80.
Armstrong EP, Patrick KL, Erstad BL. Comparison of preoperative skin preparation products. Pharmacotherapy 2001; 21:345-50.
Armstrong EP, Rhoads M, Meiling F. Medication usage patterns in assisted living facilities. The Consultant Pharmacist 2001; 16:65-9.
Armstrong EP. Treatment of resistant gram-positive pneumonias in the VA health system: clinical and economic outcome implications. Veterans Health System Journal 2000; 5:45-9.
Armstrong EP, Byrns P, Foster TS, Stockwell Morris L, Fulda TR. Drug utilization review: mechanisms to improve its effectiveness and broaden its scope. Journal of the American Pharmacists Association 2000; 40:538-45.
Armstrong EP, Abarca J. Pharmacoeconomic model to evaluate new influenza treatments. Formulary 2000; 35:169-81.
Armstrong EP, Chrischilles EA. Electronic prescribing and monitoring are needed to improve drug use. Archives of Internal Medicine 2000.
Armstrong EP. Evaluating low molecular weight heparins within a health system: Issues and strategies. Formulary 1999; 34:144-8.
Armstrong EP. Disease management: state-of-the-art and future directions. Clinical Therapeutics 1999; 21:593-609.
Armstrong EP, Langley PL. Treatment of pneumonias in a managed-care organization. The impact of a disease management intervention on physician prescribing behavior. Disease Management & Health Outcomes 1999; 3:159-73.
Armstrong EP, Denemark CR. How pharmacists respond to on-line, real-time, DUR alerts. Journal of the American Pharmacists Association 1998; 38:149-54.
Armstrong EP, Ferguson TA. Urinary incontinence: health care resource consumption in veteran affairs medical centers. Veterans Health System Journal 1998; 3:37-42.
Armstrong EP. Evaluating disease management strategies through equilibrium analysis. New Medicine 1997; 1:30-3
Armstrong EP. Pharmacoeconomic analysis of hormone replacement therapy - implications for managed care. Journal of Managed Care Pharmacy 1997; 3:200-9.
Armstrong EP, Manuchehri F. Ambulatory care databases for managed care organizations. American Journal of Health-System Pharmacy 1997; 54:1973-83.
Armstrong EP, Markson TJ. On-line DUR messages: pharmacists’ attitudes and actions in response. Journal of the American Pharmacists Association 1997; NS37:315-20.
Armstrong EP, Bykov A, Savelli AV. Introducing formulary drug selection in Russia. American Journal of Health-System Pharmacy 1996; 53:426-8.
Armstrong EP, Langley PC. Disease management programs. American Journal of Health-System Pharmacy 1996; 53:53-58.
Armstrong EP, Proteau D. Drug utilization review in ambulatory settings: perspective of state medicaid DUR directors. Annals of Pharmacotherapy 1996; 30:1088-91.
Armstrong EP. Disease state management and its influence on health systems today. Drug Benefit Trends 1996; 8(7):18-29
Armstrong EP, Akaho E, Fujii M, Hosono K. Evaluation of teaching pharmacoeconomics to Japanese students. Journal of Pharmacy Teaching 1996; 5:67-85.
Armstrong EP. Monitoring and evaluating disease management: information requirements. Clinical Therapeutics 1996; 18:1327-33.
Armstrong EP, Akaho E, Gondoh Y. Pharmacoeconomic analysis of drug therapy. Japan Journal of Hospital Pharmacy 1995; 21:154-65.
Armstrong EP. Integrating pharmacoeconomic consideration into the therapeutic outcome equation. Pharmacy Management Advisor 1995; 3:5-7,14-6.
Bauman JL, Murphy JE, Bertino JS. Pharmacists and infectious diseases specialists. Clinical Infectious Diseases. 1998; 27:229-30.
Billups SJ, Malone DC, Carter BL. Economic outcomes of medication non-compliance. Pharmacotherapy 2000; 20(8):941-949.
Billups SJ, Okano GJ, Malone DC, Carter BL, Valuck RJ, Barnette DJ, Sintek CD. Assessing the structure and process for delivering pharmaceutical care in Veteran Affairs medical centers: the IMPROVE study. American Journal of Health-Systems Pharmacy 2000; 57:29-39.
Bootman, JL, Grizzle, AJ. The Economics of Drug Related Morbidity and Mortality - Ethical Consideration. Pharmaceutical Ethics S. Salek and A. Edger Sussex, England: John A. Wilen and Sons, Ltd. 2000
Bootman JL, Harrison D, Cox E. The Healthcare Cost of Drug-Related Morbidity and Mortality in Nursing facilities. Archives of Internal Medicine 1997; 147(Oct 13): 2089-2096.
Bootman JL, Harrison D. Pharmacoeconomics of Therapeutic Drug Monitoring. Pharmacy World and Science, 1997; 19(3): 1-4.
Bootman JL, Langley PC. Pharmacoeconomics, prescribing and the reimbursement of pharmaceuticals. Journal of Applied Therapeutics 1997; 1(1): 275-283.
Bootman JL, Milne R. Costs, Innovation and Efficiency in Antiinfective Therapy. Pharmacoeconomics 1996; 9(Supplement 1): 31-39.
Bootman JL. Pharmacoeconomics and Outcomes Research. American Journal of Health-System Pharmacists 1995; 52(3): July 15, 16-19.
Bruce S, Jackson TL. Collaborative research: Benefits for all involved. Journal of the American Pharmacists Association 2006; 46(6): 663-664.
Carl J, Erstad BL, Murphy JE, Slack MK. Infusion syringe device comparison study for medication delivery. American Journal of Health-System Pharmacy 1995; 52:1428-32.
Carter BC, Billups SJ, Malone DC, Valuck RJ, Barnette, DJ, Sintek CD. Recommended guidelines for pharmacists who provide care for patients in the IMPROVE Study. Federal Practitioner 2001; 18(1):38-46.
Carter BC, Malone DC, Ellis SL, Dombrowski R. Antihypertensive drug utilization in hypertensive veterans with complex medication profiles. Journal of Clinical Hypertension 2000; 2: 172-180.
Carter BL, Malone DC, Valuck R, Barnette DJ, Sintek C, Billups SJ. The IMPROVE study: background and study design. American Journal of Health-Systems Pharmacy 1998; 55:62-67.
Carter JT, Draugalis JR, Slack MK and Cox ER. Algorithms for Estimating Learning Opportunity and Productivity Impact at Clerkship Sites. American Journal of Pharmaceutical Education 1998; 62(3):258-265.
Carter JT, Draugalis JR, Slack MK. Estimating the impact of pharmacy students on clerkship sites: The site perspective. American Journal of Health-System Pharmacy. 1996; 53:1694-1700.
Cassady JM, DiPiro JT, Foster TS, Hak LJ, Hill WT, Kirshstein R, Lindley CM, Nahata MC, Robinson JR, Stinnett AA, Murphy JE, Manasse HR, Witmer DR. Report of the ASHP Task Force on Science. American Journal of Health-System Pharmacy 1998; 55 (23): 2519-24.
Chinburapa V, Larson LN, Bootman JL, et al. Prescribing intentions and relative importance of drug attributes: a comparative study by HMO and fee-for-service physicians. Journal of Pharmaceutical Marketing and Management 1987; 2(2):89-105.
Chinburapa V, Larson LN, Brucks M, Draugalis JR, Bootman JL, Puto CP. Physician prescribing decisions: the effects of situational involvement and task complexity on information acquisition and decision making. Social Science and Medicine 1993;36(11):1473-1482.
Clemens K, Garrison LP, Jones (Grizzle) A, Macdonald F. Strategic Use of Pharmacoeconomic Research in Early Drug Development and Global Pricing. Pharmacoeconomics 1993;4(5):315-322.
Cox ER, Krueger KP, Murphy JE. Pharmacy student involvement in student organizations. Journal of Pharmacy Teaching 1998; 6:9-18.
Daniel GW. Malone DC. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs. Journal of Managed Care Pharmacy 2007; 13:142-154.
Draugalis JR, Carter JT, Slack MK. A survey course on research methods: Integrating statistical analysis and study design. American Journal of Pharmaceutical Education. 1998;62:17-24.
Draugalis JR, Carter JT, Slack MK. Curricular and financial implications of PharmD clerkship placements. American Journal of Pharmaceutical Education 1996; 60(2):146-151.
Einarson TR, Larson LN, Bootman JL, McGhan WF. Financial feasibility of establishing a blood level testing service in a community pharmacy. American Pharmacy 1988; 28(3):76-79.
Elliot WJ, Plauschinat CA, Skrepnek GH, Gausse D. Persistence, Compliance, and Risk of Discontinuation Associated with Commonly Prescribed Antihypertensive Drug Monotherapy. Journal of the American Board of Family Medicine 2007; 20:72-80.
Ellis SA, Billups SJ, Malone DC, Carter BL, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Soloboda L, Sintek CD, Geraets DR, Dombrowski R, Amata M. Ambulatory care clinical pharmacist interventions: the IMPROVE study. Pharmacotherapy 2000; 20(4):429-435.
Ellis SL, Carter BL, Malone DC, Valuck RJ, Barnette, DJ, Sintek CD, Okano GJ, Ellis SL, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sloboda L, Dombrowski R, Gereats DR, Amato MG. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: The IMPROVE Study. Pharmacotherapy 2000; 20(12):1508-1516.
Else BA, Armstrong EP, Cox ER. Data sources for pharmacoeconomic and health services research. American Journal of Health-System Pharmacy 1997; 54:2601-8.
Ernst FR and Grizzle AJ. Drug-Related Morbidity and Mortality: Updating the cost-of-illness model. Journal of the American Pharmacists Association 2001; 41:192-9.
Erstad AJ, Erstad BL, Nix DE. Accuracy and reproducibility of small-volume injections from various-sized syringes. American Journal of Health-System Pharmacy 2006; 63:748-50.
Ford J, Murphy JE. A survey of community chain pharmacists' attitudes and awareness on domestic abuse. Journal of the American Pharmaceutical Association. 1996; NS36:323-8.
Gardner M, Malone DC, Babington M, Sey M. Mirtazapine Is Associated with Less Anxiolytic Use among Elderly Depressed Patients in Long-Term Care Facilities. Journal of the American Medical Directors Association 2004; 5:101-106.
Grizzle AJ, Olson BM, Motheral BR, Armstrong EP, Abarca J, Cox ER. Therapeutic Value: Who Decides? Pharmaceutical Executive November 2000; 84-90.
Grizzle AJ. A Critical Assessment of a Model-Based Economic Evaluation of BPH Treatment Options. Formulary 2000: 35:353-8.
Groce JB, Murphy JE. Unfractionated heparin and low molecular weight heparin. In: Murphy JE, ed. Clinical pharmacokinetics pocket reference, 3rd edition. Bethesda: American Society of Health-System Pharmacists, Inc.; 2005:169-200.
Grudzinsky AN, Hakim Z, Cox E, Bootman JL. The Economics of Multiple Sclerosis; Distribution of Costs and Relationship to Disease Severity. Pharmacoeconomics 1999 Mar; 15(3): 229-240.
Gwyn BC, Malone DC, Valuck RJ, Schafermeyer KW. 1996 Colorado cost of dispensing study. Colorado Pharmacist 1997; 28(3): 15-17.
Harrison DL, Bootman JL, and Cox ER. Cost effectiveness of consultant pharmacists in managing drug-related morbidity and mortality at nursing facilities. American Journal of Health-System Pharmacy 1998; 55:1588-1594.
Harrison DL, Draugalis JR, Slack MK, Langley PC. Cost-effectiveness of regional poison control centers. Archives of Internal Medicine 1996; 156:2601-2608.
Harrison DL, Slack MK. Meta-analytic review of the effect of subcutaneous sumatriptin in migraine headaches. Journal of Pharmacy Technology 1996; 12:109-114.
Harrison DL, Draugalis JR, Slack MK, Tong TG. The production model as a basis for conducting economic evaluations of regional poison control centers. Clinical Toxicology 1995; 33(3):233-237.
Hassenplug K, Burkiewicz J, Jackson T, Peppers L. Effect of pharmacist education on patient knowledge of nosebleed management: An anticoagulation clinic intervention. American Journal of Health-System Pharmacy 2006; 63(May 15): 909-911.
Hess LM, Raebel MR, Conner DA, Malone DC. The measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Annals of Pharmacotherapy 2006; 40:1280-1288.
Hess LM, Sadoda K, Malone DC, Salache S, Warneke J, Alberts DS. Adherence assessment using medication weight in a phase IIb clinical trial of difluoromethylornithine for the chemoprevention of skin cancer. Cancer Epidemiology and Biomarkers Prevention 2005; 14:2579-2583.
Isaksen SF, Jonassen J, Malone DC, Billups SJ, Carter BL, Sintek CD. Estimating risk factors for patients with potential drug related problems using electronic pharmacy data. The Annals of Pharmacotherapy 1999; 33: 406-412.
Jackson TL, Stensland SL, Todd TJ, Lullo A, Mazan A, Masood AM. Assessment of a pediatric asthma awareness program. Journal of Asthma 2006; 43: 311-317.
Jackson TL. Ensuring quality in pharmacy operations. pp 125-149. In: Pharmacy Management. Desselle S and Zgarrick D (Eds). McGraw Hill Companies, Inc. 2005
Jackson TL, McCord AD, Dahdal WY, Zgarrick DP, Brock K. The use of a scholarship committee to foster scholarly growth of pharmacy practice faculty. American Journal of Pharmaceutical Education. 2005; 69(5): Article 1519.
Jackson TL. Application of quality assurance principles: Teaching students medication error reduction skills in a “Real World” environment. American Journal of Pharmaceutical Education. 2004; 68(1) Article 17.
Jackson TL. Decreasing medication errors in the community pharmacy. Drug Store News CEQ. Spring 2004; 66-70.
Jackson TL, Rupp MT, Newton GD. Evaluation of a clinical decision aid and training program on the quality of pharmacists’ prospective drug utilization review decisions. American Journal of Pharmaceutical Education 2002; 66: 260-267.
Jackson TL. QA for Pharmacy Students. In: Introductory Pharmacy Practice Experience Practice Manual Part 1: Community (PPRA 0341). Midwestern University Chicago College of Pharmacy. September 17, 2002.
Jackson TL. Evaluation of a systematic process for conducting prospective drug utilization review in pharmacy practice. Dissertation. Purdue University Press: West Lafayette, IN; 2001.
Back to top
Johnson JA, Bootman JL. Drug-related morbidity and mortality: A cost-of-illness model. Archives of Internal Medicine 1995; 155:1949-1956.
Joish VN, Malone DC, Wendel C, Draugalis JR, Mohler MJ. Development and validation of a diabetes severity index (DSI): a risk adjustment tool for predicting healthcare resource use and costs. Pharmacotherapy 2005; 25:676-684.
Joish V, Malone DC, Wendal C, Mohler MJ. Profiling quality of diabetes care in a Veterans Affairs health care system. American Journal of Medical Quality 2004; 19(3);112-120.
Joish V, Malone DC, Miller JM. A cost benefit analysis of vision screening methods for preschoolers and school-aged children. Journal of AAPOS 2003; 7:283-290.
Joish VN, Limcangco MRMT, Armstrong EP. Cost-benefit analysis of a pharmacist-advocated pneumococcal vaccination program. Formulary 2001;36:147-56.
Joish VN, Armstrong EP. Use of decision analysis in modeling the cost-effectiveness of oral vs SC sumatriptan. Formulary 2000; 35:532-9.
Jones (Grizzle) AJ. Sources of pharmacoeconomics and outcomes data for medical professionals. New Medicine 1997; 1:27-30.
Jones (Grizzle) AJ and Sanchez LA. Pharmacoeconomic evaluation: Applications in managed health care formulary decision making. Drug Benefit Trends 1995; 7:12-34.
Kelly RM, Meyer JD, Matsuura JE, Hart MJ, Malone DC, Manning MC. In vitro release kinetics of gentamycin from a sodium hyaluronate gel delivery system suitable for the treatment of peripheral vestibular disease. Drug Development and Industrial Pharmacy 1999; 25: 15-20.
Ko Y, Abarca J, Malone DC, Dare DC, Geraets D, Houranieh A, Jones WN, Nichol WP, Schepers GP, Wilhardt M. Practitioners’ views on computerized drug-drug interaction alerts in the VA system. Journal of the American Medical Informatics Association 2007; 14:56-64.
Ko Y, Malone DC, Armstrong EP. A pharmacoeconomic evaluation of antimuscarinic agents for the treatment of overactive bladder. Pharmacotherapy 2006; 26:1694-1702.
Kopp, BJ, Erstad, BL, Allen, ME, Theodorou AA, Priestly G. Medication errors and adverse drug events in an intensive care unit: Direct observation approach for detection. Critical Care Medicine 2006; 34:415-25
Kortt MA, Armstrong EP. Cholesterol-lowering therapy interventions: a pharmacoeconomic assessment. Disease Management & Health Outcomes 1998; 4:193-203.
Lackner TE, Heard T, Glunz S, Gann N, Babington M, Malone DC. Gastrointestinal disease control after histamine2-receptor antagonist dose modification for renal impairment in frail chronically-ill elderly patients. Journal of the American Geriatrics Association 2003; 51:650-656.
Lai L, Armstrong EP, French R, Salcido A, Skrepnek GH. Women’s Perception of Bone-Mineral Density Screening and Osteoporosis Education in the Community Pharmacy. The Consultant Pharmacist 2003; 18:968-976.
Langley PC, Langley-Hawthorne CE, Martin RE, Armstrong EP. Establishing the basis for successful disease management contracting. American Journal of Managed Care 1996;2(8):1099-1108.
Lee M, Bennett M, Chase P, Gourley D, Letendre D, Murphy JE, Nappi J, Nelson A, Taylor C, Speedie M, Carter R. Final Report and Recommendations of the 2002 AACP Task Force on the Role of Colleges and Schools in Residency Training. American Journal of Pharmaceutical Education 2004; 68(1)S2.
Lipsy RJ, Armstrong EP. Clinical Practice Guidelines. In: American College of Clinical Pharmacy, Pharmacotherapy Self-Assessment Program, third edition; 1999.
Lousberg TR, Witt DM, Beall DG, Carter BL, Malone DC. Evaluation of excessive anticoagulation in a group model health maintenance organization. Archives of Internal Medicine 1998; 158: 528-534.
MacLaughlin EJ, Saseen JJ, Malone DC. Selection and costs of antibiotics for patients with a reported beta-lactam allergy. Archives of Family Medicine 2000; 9:722-726.
Malone DC, Abarca J, Skrepnek GH, Murphy JE, Armstrong EP, Grizzle AJ, Rehfeld RA, Woosley RL. Pharmacist Workload and Pharmacy Characteristics Associated with the Dispensing of Potentially Clinically Important Drug-drug Interactions. Medical Care 2007; 45:456-462
Malone DC, Tran TT, Poordad FF. Cost-efficacy analysis of peginterferon alfa-2b plus ribavirin compared with peginterferon alfa-2a plus ribavirin for the treatment of chronic hepatitis C. Journal of Managed Care Pharmacy 2005; 11:687-94.
Malone DC, Hutchins DS, Haupert H, Hansten P, Duncan B, Van Bergen RC, Solomon SL, Lipton RB. Assessment of potential drug–drug interactions with a prescription claims database. American Journal of Health-Systems Pharmacy 2005 62: 1983-1991.
Malone DC, Raebel MA, Porter JA, Lanty FA, Conner DA, Gay EC, Merenich JA, Vogel EA. Cost-effectiveness of sibutramine in the LOSE weight study: evaluating the role of pharmacological weight-loss therapy within a weight management program. Journal of Managed Care Pharmacy 2005; 11:458-468.
Malone DC, Abarca J, Hansten PD, Grizzle AJ, Armstrong EP, Van Bergen R, Duncan-Edgar BS, Solomon SL, Lipton RL. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. Journal of the American Pharmacist Association 2004: 44:142-151.
Malone DC, Luskin AT. Hydrofluoroalkane-134a beclomethasone as a dominant economic asthma therapy. Respiratory Medicine 2003; 97:1269-1276.
Malone DC, Sullivan SD, Veenstra DL. Determining unit cost values for health care resources in pharmacoeconomic studies. Formulary 2001:36:294-304.
Malone DC, Armstrong EP. Economic burden of asthma: implications for outcomes and cost-effectiveness analysis. Expert Review of Pharmacoeconomics & Outcomes Research 2001; 1:177-186.
Malone DC, Mubarak-Shaban H. Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia. Annals of Pharmacotherapy 2001; 35:1180-1185.
Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette, DJ, Sintek CD, Okano GJ, Ellis SL, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sloboda L, Dombrowski R, Gereats DR, Amato MG. Can Clinical Pharmacists Affect SF-36 Scores in Veterans at High-Risk For Medication-Related Problems? Medical Care 2001:39:109-112.
Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette, DJ, Sintek CD, Okano GJ, Ellis SL, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sloboda L, Dombrowski R, Gereats DR, Amato MG. An economic analysis of a randomized controlled multi-center study of clinical pharmacist interventions for high-risk veterans: The IMPROVE Study. Pharmacotherapy 2000; 20(10):1149-1158.
Malone DC. Article critique: cost-effective analysis of interferon alpha-2b with ribavirin for chronic hepatitis C infection. Formulary 2000; 35:681-689.
Malone DC, Lawson KA, Smith DH. Asthma: analysis of high-cost patients. Pharmacy Practice Management Quarterly 2000; 20:12-20.
Malone DC, Rascati KL, Martin JD. An analysis of the product-liability costs borne by prescription drug manufacturers. Research in Finance 1999; 17:173-189.
Malone DC, Okano GJ. Treatment of urge incontinence in Veterans Affairs medical centers. Clinical Therapeutics 1999; 21: 867-877.
Malone DC, Billups SJ, Valuck RJ, Carter BL. Development of a Chronic Disease Indicator Score Using a Veterans Affairs Medical Center Medication Database. Journal of Clinical Epidemiology 1999; 52:551-557.
Malone DC, Lackner T, Korenblat BM, Babington M, Yoon P. A clinical and economic comparison of nifedipine CC and nifedipine GITS in long-term care patients. The Consultant Pharmacist 1998; 13(2): 182-192.
Malone DC, Gwyn BC. Consultant pharmacist services and payment in long-term care facilities. The Consultant Pharmacist 1997; 12: 781-790.
Malone DC, Lawson KA, Smith DH, Arrighi HM, and Battista C. A Cost of illness study of allergic rhinitis in the United States. Journal of Allergy and Clinical Immunology 1997; 99:22-27.
Malone, DC. Carve outs and pharmacy: fashion or fad? Journal of Managed Care Pharmacy 1996; 2(4): 352-359.
McAndrews KL, Murphy JE. Aminoglycoside pharmacokinetics in Alaskan Natives. American Journal of Health-System Pharmacy 1995; 52:2015-8.
Millonig MK, Jackson TL, Ellis WM. Improving medication use through pharmacists’ access to patient-specific health care information. Journal of the American Pharmacists Association. 2002; 42: 638-43.
Motheral BR, Grizzle AJ, Armstrong EP, Cox E. Role of pharmacoeconomics on drug benefit decision-making: Results of a survey. Formulary 2000; 35:412-21.
Murphy JE, Malone DC, Skrepnek GH, Armstrong EP, Abarca J, Grizzle AJ, Rehfeld R, Woosley RL. The role of technicians in the management of computerized drug-drug interaction alerts in community pharmacies. Journal of Pharmacy Technology 2006; 22:155-160.
Murphy JE, Nappi J, Bosso J, Saseen JJ, Hemstreet B, Halloran MA, et al. American College of Clinical Pharmacy’s vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice. Pharmacotherapy 2006; 26(5):722-33.
Murphy JE. The prevention of medication misadventures. European Journal of Hospital Pharmacy Science: Jan/Feb 2006; 24:25-26.
Murphy JE, Barzanjy S, Nguyen Y, Bateman CV. Aminoglycoside pharmacokinetics and evaluation of predicted concentrations from large dose, extended interval dosing protocols. European Journal of Hospital Pharmacy – Science 2006; 12(5):67-71.
Murphy JE, Gillespie DE, Bateman CV. Predictability of vancomycin trough concentrations using seven approaches for estimating pharmacokinetic parameters. American Journal of Health-System Pharmacy 2006; 63:2365-70.
Murphy JE, Sasseen JE, Nappi J, Bosso JA. Comments on draft of workforce document. American Journal of Health-System Pharmacy 2006; 63:1592.
Murphy JE. Prediction of gentamicin peak and trough concentrations from six extended-interval dosing protocols for neonates. American Journal of Health-System Pharmacy 2005; 62:823-7.
Murphy JE, Forrey RA, Desiraju U. Community pharmacists’ responses to drug-drug interaction alerts. American Journal of Health-System Pharmacy 2004; 61:1484-7.
Murphy JE. New Zealand revisited. American Journal of Health-System Pharmacy 2004; 61:1176-7.
Murphy JE, Valenzuela R. Attitudes of doctor of pharmacy graduates of one U.S. college toward required evaluative projects and research-related coursework. Pharmacy education : an international journal for pharmaceutical education 2002; 2:69-73.
Murphy JE. Value of residency projects. American Journal of Health-System Pharmacy 2002; 59:382-3.
Murphy JE, Downhour N. Perceived value and outcomes of residency projects. American Journal of Health-System Pharmacy 2001; 58:889-95.
Murphy JE, Driscoll DF, Mirtallo JM, Rollins CJ, Sacks GS. Multivitamins in parenteral nutrition therapy. Special Report 2001:1-8. Pharmacy Practice News.
Murphy JE. Using benchmarking data to evaluate and support pharmacy programs in health systems. American Journal of Health-System Pharmacy 2000; 57 (Supplement 2):S28-S31.
Murphy JE. Epistaxis associated with elevation of INR in a patient switched to generic warfarin –A comment. Pharmacotherapy 2000; 20:863-5.
Murphy JE. Generic substitution and optimal patient care. Archives of Internal Medicine 1999; 159:429-33.
Murphy JE, Sickels J, Bradberry JC, Curry CE, Jungnickel PW, Prosser T. Opportunities for pharmacy specialists as the delivery of health care changes. American Journal of Health-System Pharmacy 1999; 56:1342-7.
Murphy JE, Peralta L, Kirking DM. Research experiences and research-related coursework in the education of Doctors of Pharmacy. Pharmacotherapy 1999; 19:213-20.
Murphy, JE. A call to arms. American Journal of Health-System Pharmacy 1999; 56:672-3.
Murphy JE, Austin ML, Frye RF. Evaluation of gentamicin pharmacokinetics and dosing protocols in 195 neonates. American Journal of Health-System Pharmacy 1998; 55:2280-8.
Murphy JE. Pharmacy practice in the United States: Current status and future opportunities. Journal of Japanese Society of Hospital Pharmacists 1998; 34:1301-7.
Murphy JE. Rededicating ourselves to service: Becoming the ‘visible’ ingredient in health care. American Journal of Health-System Pharmacy 1998; 55:1692-6.
Murphy JE. Therapeutic drug monitoring: Observations and recommendations. American Journal of Health-System Pharmacy 1998; 55:1306-7.
Murphy JE. Faculty attitudes toward required evaluative projects for doctor of pharmacy candidates. American Journal of Pharmaceutical Education 1997; 61:74-78.
Murphy JE. Service as the prime directive: Make it so. American Journal of Health-System Pharmacy 1997; 54:1865-7. (ASHP Presidential speech)
Murphy JE, Slack MK, Campbell S. A national survey of hospital-based pharmacokinetic services. American Journal of Health-System Pharmacy 1996; 53:2840-7.
Murphy JE, Winter ME. Clinical pharmacokinetic pearls: Using bolus vs infusion equations. Pharmacotherapy 1996; 16:698-700.
Murphy JE. The writing on the wall: An allegory of fish management. Pharmacotherapy 1996; 16:721-2.
Murphy JE. Confessions of a pharmacy thief. American Journal of Health-System Pharmacy 1996; 53:2522-3.
Murphy JE, Job ML, Ward ES. Dosing error due to use of adult concentration of gentamicin injection rather than the pediatric concentration. Hospital Pharmacy 1996; 31:219-20,230.
Murphy JE, Carter JT. Evaluation of gentamicin therapy in newborns at a community hospital and development of simple dosing guidelines. Hospital Pharmacy 1996; 31:1283-9.
Murphy JE, Severnak T. Aminoglycoside pharmacokinetics in Native Americans of Apache ancestry. American Journal of Health-System Pharmacy 1996; 53:2189-91.
Nix DF, Erstad BL, Nakazato PZ, et al. Estimation of creatinine clearance in end-stage liver disease. Annals of Pharmacotherapy 2006; 40:900-8
Nix D, Murphy JE. Basic bibliographies: clinical pharmacokinetics - 1997. Hospital Pharmacy 1997; 32:1694.
Okano GJ, Malone DC, Billups SJ, Carter BL, Sintek CD, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sloboda L, Dombrowski R, Gereats DR, Amato MG. Reduced quality of life in veterans at risk for drug related problems. Pharmacotherapy 2001; 21(9):1123-1129.
Olson BM, Armstrong EP, Grizzle AJ, Nichter MA. Industry's perception of presenting pharmacoeconomic models to managed care organizations. Journal of Managed Care Pharmacy 2003; 9(2):159-167.
Patanwala A, Abarca J, Huckleberry Y, Erstad BL. Pharmacologic management of constipation in the critically ill patient. Pharmacotherapy 2006; 26:896-902.
Perkins NA, Murphy JE, Armstrong EP, Malone DC. Performance of drug-drug interaction software for personal digital assistants. Pharmacotherapy 2006; 40:850-855.
Plaza, CM, Draugalis JR, Skrepnek GH, Slack MK. Administrative Mentoring and Career Planning in the Pharmacy Deanship. American Journal of Pharmaceutical Education 2004; 68(4):1-12.
Plaza CM, Draugalis JR, Slack MK, Skrepnek GH. Administrative Career Planning: A Ten-Year Update of the Pharmacy Deanship. American Journal of Pharmaceutical Education 2004; 68(1):1-8.
Pursel MB, Armstrong EP. The place of disease-based analysis and pharmaceutical care in drug utilization review. Managed Care Pharmacy Practice 1996; 3:31-9.
Raebel MA, Malone DC, Conner DA, Xu S, Porter JA, Lanty FA. Health services use and health care costs of obese and non-obese health maintenance organization members. Archives of Internal Medicine 2004: 164:2135-2140.
Reddick JB, Murphy JE. Evaluating the clinical interventions of students during clerkships using a cognitive services claim form. American Journal of Pharmaceutical Education 2000; 64:38-43.
Romero AV, Malone DC. Accuracy of adverse-drug-event reports collected using an automated dispensing system. American Journal of Health-System Pharmacy 2005; 62:1375-1380.
Saseen JJ, Grady SE, Hansen LB, Hodges BM, Kovacs SJ, Martinez LD, Murphy JE, Page RL, Reichert MG, Stringer KA, Taylor CT. ACCP White Paper: Future clinical pharmacy practitioners should be board-certified specialists. Pharmacotherapy 2006; 26:1816-25.
Schwarz HO, Savelli AV, Armstrong EP. Drug formulary development in the Newly Independent States. American Journal of Health-System Pharmacy 1998; 55:1308-11.
Skrepnek GH, Armstrong EP, Malone DC, Abarca J, Murphy JE, Grizzle AJ, Rehfeld RA, Woosley RL. Workload and the availability of technology in community pharmacy practice. Journal of the American Pharmacist Association 2006; 46(2):154-160.
Skrepnek GH, Abarca J, Malone DC, Armstrong EP, Shirazi FM, Woosley RL. Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs. Annals of Pharmacotherapy 2005; 39:1785-91.
Skrepnek GH, Bootman JL. Patient Safety and Medication Errors. Italian Journal of Public Health 2005; 2(3-4):25-33.
Skrepnek GH, Abarca J, Malone DC, Armstrong EP, Shirazi FM, Woosley RL. Incremental Effects of Concurrent Pharmacotherapeutic Regimens for Heart Failure on Hospitalizations and Costs. Annals of Pharmacotherapy 2005; 39:1785-1791.
Skrepnek GH. The Cost-Effectiveness of HMG-CoA Reductase Inhibitors in the Treatment of Dyslipidemia and Prevention of Coronary Heart Disease (CHD). Expert Review in Pharmacoeconomics and Outcomes Research 2005; 5:603-623.
Skrepnek GH. Regression Methods in the Empiric Analysis of Health Care Data. Journal of Managed Care Pharmacy 2005; 11:240-251.
Skrepnek GH, Ballard EE. Cost-Efficacy of Imatinib versus Allogeneic Bone Marrow Transplantation with a Matched Unrelated Donor in the Treatment of Chronic Myelogenous Leukemia: A Decision-Analytic Approach. Pharmacotherapy 2005; 25:325-334.
Skrepnek GH, Armstrong EP, Malone DC, Ramachandran S. An Economic and Clinical Assessment of First-Line Monotherapy in the Treatment of Community-Acquired Pneumonia within Managed Care. Current Medical Research and Opinion 2005; 21:261-270.
Skrepnek GH. Accounting versus Economic Rates of Return: Implications for Profitability Measures in the Pharmaceutical Industry. Clinical Therapeutics 2004; 26:155-174.
Skrepnek GH, Skrepnek SV. Epidemiology, Clinical and Economic Burden, and Natural History of Chronic Obstructive Pulmonary Disease and Asthma. American Journal of Managed Care 2004; 10s:129-138.
Skrepnek GH, Skrepnek SV. An Assessment of Therapeutic Regimens in the Treatment of Acute Exacerbations in Chronic Obstructive Pulmonary Disease and Asthma. American Journal of Managed Care 2004; 10s:139-152.
Skrepnek GH, Lawson KA. Measuring Changes in Capital Market Security Prices: The Event Study Methodology. Journal of Research in Pharmaceutical Economics 2001;11:1-17.
Skrepnek GH, Lawson KA. The Effect of Merger and Acquisition Activity on Shareholder Returns in the Pharmaceutical Industry. Journal of Research in Pharmaceutical Economics 2001; 11:19-38.
Slack MK, McEwen MM. An Interdisciplinary Problem Based Practicum in Case Management and Rural Border Health. Family and Community Health 1997; 20:40-53.
Slack MK. Interpreting and using information from studies without statistical significance. Annals of Pharmacotherapy 1997; 31:116-117.
Slack MK, McEwen MM, Carter JT, Brueckner R. Implications of Case Management Delivery Models for Pharmacy. American Journal of Health-System Pharmacy 1996;53:2860-7.
Slack MK, Brookes AJ. Medication management issues important to adolescents with asthma. American Journal of Hospital Pharmacy 1995; 52:1417-1421.
Slack MK, Murphy JE. The factors associated with student membership in professional organizations. American Journal of Pharmaceutical Education 1995; 59(2):125-130.
Smith DH, Malone DC, Lawson KL, Okamoto LJ, Battista C, and Saunders WB. A national estimate of the economic costs of asthma. American Journal of Respiratory and Critical Care Medicine 1997; 156: 787-793.
Tordoff JM, Murphy JE, Norris PT, Reith DM. Evaluation of the utility of centralized pharmacoeconomic assessments for local formulary decisions. American Journal of Health-System Pharmacy 2006; 63:1613-8.
VanDenBerg C, Murphy JE. Satisfaction among residents in ASHP-accredited pharmacy residency programs. American Journal of Health-System Pharmacy 1997; 54:1521-7.
Ventura D, Armstrong EP, Skrepnek GH, Erder MH. Escitalopram versus Sertraline in the Treatment of Major Depressive Disorder: A Randomized Comparative Clinical Trial. Current Medical Research and Opinion 2007; 23:245-250.
Warholak-Juarez T, Rupp MT, Salazar TA, Foster S. The effect of patient information on pharmacists’ drug use review decisions. Journal of the American Pharmacists Association. 2000; 40:500-8.
Wieland LD, Murphy JE. Postgraduate education and professional training requirements for pharmacy management, clinical pharmacist, and clinical faculty positions. American Journal of Health-System Pharmacy 1996;53:289-93
Yeh, Wei-Shi, Armstrong EP, Skrepnek GH, Malone DC. Peginterferon alfa-2a versus Peginterferon alfa-2b as Initial Treatment of Hepatitis C Virus Infection: A Cost-Utility Analysis from the Perspective of the Veterans Affairs Health Care System. Pharmacotherapy 2007; 27(6):813-824.
Zachry WM, Skrepnek GH. Applying Multiattribute Utility Technology to the Formulary Evaluation Process. Formulary 2002; 38:199-206.
Zachry WM, Armstrong EP. Health care professionals perceptions of the role of pharmacogenomic data. Journal of Managed Care Pharmacy 2002; 8:278-84.
Zarembski DG, Nolan PE, Slack MK, Lui CY. Meta-Analysis of the Use of Low-Dose Beta-Adrenergic Blocking Therapy in Idiopathic or Ischemic Dilated Cardiomyopathy. American Journal of Cardiology 1996; 77:1247-50.
Zarembski DG, Nolan PE, Slack MK, Caruso AC. Treatment of resistant atrial fibrillation: A meta-analysis comparing amiodarone and flecanide. Archives of Internal Medicine 1995; 155:1885-1891.